Aktie CASCADIAN THERAPEUTICS INC (USA)
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Cascadian Therapeutics Inc (USA)

Aktien

US14740B6065

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Cascadian Therapeutics Announces 2018 Outlook and Recent Progress
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency
Cascadian Therapeutics Added to the Nasdaq Biotechnology Index
Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer
Cascadian Therapeutics Reports Third Quarter 2017 Financial Results
Cascadian Therapeutics to Report Third Quarter 2017 Financial Results on November 8, 2017
Cascadian Therapeutics to Participate in Panel Discussions at Two Conferences in November
Cascadian Therapeutics Announces FDA Orphan Drug Designation Granted to Tucatinib for the Treatment of HER2+ Metastatic Colorectal Cancer
Cascadian Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
Tucatinib Data in Multiple Tumor Types Presented at the European Society for Medical Oncology (ESMO) 2017 Congress
Cascadian Therapeutics Announces Poster Presentations on Tucatinib in Multiple Tumor Types at the European Society for Medical Oncology (ESMO) 2017 Congress
Cascadian Therapeutics Reports Second Quarter 2017 Financial Results
Cascadian Therapeutics to Report Second Quarter 2017 Financial Results on August 8, 2017
Cascadian Therapeutics Announces Positive Regulatory Update for Tucatinib in Europe
Oncothyreon USA : Cascadian Therapeutics' Lead Candidate, Tucatinib, Receives Orphan Drug Designation from FDA for Treatment of Breast Cancer Patients with Brain Metastases
Cascadian Therapeutics’ Lead Candidate, Tucatinib, Receives Orphan Drug Designation from FDA for Treatment of Breast Cancer Patients with Brain Metastases
Cascadian Therapeutics to Present at Jefferies 2017 Healthcare Conference
Cascadian Therapeutics Reports First Quarter 2017 Financial Results Conference Call Scheduled for Today at 8:30 a.m. ET
Cascadian Therapeutics to Report First Quarter 2017 Financial Results on May 9, 2017
Cascadian Therapeutics Highlights Preclinical Program Presentations at the American Association for Cancer Research Annual Meeting 2017
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. Aktie
  4. Nachrichten Cascadian Therapeutics Inc (USA)
  5. Andere Sprachen